Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

New Name, Coherent is a Compelling AI Data Infrastructure Play: https://www.marketbeat.com/logos/articles/med_20230702163236_chart-cohr.jpg
New Name, Coherent is a Compelling AI Data Infrastructure Play

Laser systems maker Coherent Co. (NASDAQ: COHR) changed its name from II-VI, confusing investors even trying to pronounce the name. The company is undergoing a multi-year restructuring plan to

Is It Time to Get into Piedmont Lithium Pre-Production?: https://www.marketbeat.com/logos/articles/med_20230705140314_is-it-time-to-get-into-piedmont-lithium-pre-produc.jpg
Is It Time to Get into Piedmont Lithium Pre-Production?

Development-stage integrated lithium company Piedmont Lithium Inc. (NYSE: PLL) stock has been trading in an ever tighter trading range. Lithium is crucial for operating electric vehicles (EVs) as

Yield Curve Tests New Lows, Where Markets Are Seeking Safety: https://www.marketbeat.com/logos/articles/med_20230705105219_yield-curve-tests-new-lows-where-markets-are-seeki.jpg
Yield Curve Tests New Lows, Where Markets Are Seeking Safety

As markets come to a significant turning point, investors can benefit from understanding where money has been and where it may be going into, as pivots in the flow of investment preferences

Is BioMarin Ready To Rebound After FDA Approval Of Roctavian?: https://www.marketbeat.com/logos/articles/med_20230705113839_copy-1-of-chart-bmrn-752023.png
Is BioMarin Ready To Rebound After FDA Approval Of Roctavian?

BioMarin (NASDAQ: BMRN) shares have been under pressure due to delays in approving its hemophilia A drug Roctavian. That is over. The drug, which targets hemophilia A in a 1-time treatment, was

Wall Street Is Cautious on These 2 First Half Winners: https://www.marketbeat.com/logos/articles/med_20230705112753_wall-street-is-cautious-on-these-2-first-half-winn.jpg
Wall Street Is Cautious on These 2 First Half Winners

Lately, it seems like the only thing that can stop the U.S. equity markets is a holiday early close. Heading into the 4th of July celebration, major stock indices are enjoying a festive 2023

$1 Billion Deal For Moderna To Expand Product Pipeline in China: https://www.marketbeat.com/logos/articles/med_20230705112152_1-billion-deal-for-moderna-to-expand-product-pipel.jpg
$1 Billion Deal For Moderna To Expand Product Pipeline in China

The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in the money markets

Kopin Corp is the Technology Seen Behind Smart AR Glasses: https://www.marketbeat.com/logos/articles/med_20230702162859_chart-kopn2.jpg
Kopin Corp is the Technology Seen Behind Smart AR Glasses

High-resolution microdisplay maker Kopin Co. (NASDAQ: KOPN) stock is still trading down over 80% from its $13.62 post-COVID highs in 2021. The business has improved since then, but shares are

Two 1st Half Underperformers That Wall Street Loves: https://www.marketbeat.com/logos/articles/med_20230705110410_two-1st-half-underperformers-that-wall-street-love.jpg
Two 1st Half Underperformers That Wall Street Loves

Whether it’s a league-leading sports team or a perennial favorite thoroughbred, it’s easy to get behind a winner. The thrill of victory. An innate desire to be associated with a winner

Rooting

National Beverage Corp. Underperforms Buy These Stocks Instead: https://www.marketbeat.com/logos/articles/med_20230705095810_copy-1-of-chart-fizz-752023.png
National Beverage Corp. Underperforms Buy These Stocks Instead

National Beverage Corp. (NASDAQ: FIZZ) stock has outperformed other beverage companies since the pandemic bottom and even in 2023, but that is about to change. The company offers little reason to

A Closer Look At The Recent Move In Rivian Stock: https://www.marketbeat.com/logos/articles/med_20230705104425_a-closer-look-at-the-recent-move-in-rivian-stock.jpg
A Closer Look At The Recent Move In Rivian Stock

Rivian Automotive (NASDAQ: RIVN) has been on an impressive run lately. Over the last month, shares of the EV automaker are up 36.40%. Just several days ago, the stock was negative YTD. However

3 Russell 2000 Stocks to Buy as Small-Caps Make a Comeback: https://www.marketbeat.com/logos/articles/med_20230705102931_3-russell-2000-stocks-to-buy-as-small-caps-make-a.jpg
3 Russell 2000 Stocks to Buy as Small-Caps Make a Comeback

The Russell 2000 Index (INDEXRUSSELL: RUT) is a market index made up of 2,000 small-cap companies. The companies in the index make up the bottom two-thirds of company size in the Russell 3000

These Banks Are Boosting Dividends After Safe Stress Tests: https://www.marketbeat.com/logos/articles/med_20230705101401_these-banks-are-boosting-dividends-after-safe-stre.jpg
These Banks Are Boosting Dividends After Safe Stress Tests

After the collapse of Silicon Valley Bank (NASDAQ: SIVB) a few months ago, regional and larger banks across the United States saw their stocks decline as a systematic reaction to the news. As is a

Three (3) Stocks Under $10 That Insiders Are Buying: https://www.marketbeat.com/logos/articles/med_20230703120408_chart-cmtl-732023.png
Three (3) Stocks Under $10 That Insiders Are Buying

Insider buying is almost always a good signal that a stock is undervalued, and today’s list includes 3 that also trade for less than $10 per share. The takeaway is that Comtech Telecommunications

3 Cash-Rich Defensive Companies Making Investors Rich: https://www.marketbeat.com/logos/articles/med_20230705090053_3-cash-rich-defensive-companies-making-investors-r.jpg
3 Cash-Rich Defensive Companies Making Investors Rich

The phrase “cash is king” can mean several different things depending on perspective. 

To a local restaurant that only accepts cash payments, ‘cash is king.’ To investors in an overheated stock

Can Valero Energy Corporation Rise To New Highs In 2023?: https://www.marketbeat.com/logos/articles/med_20230705080458_chart-vlo-752023.png
Can Valero Energy Corporation Rise To New Highs In 2023?

Whether or not Valero Energy Corporation (NYSE: VLO) can reach new highs in 2023 is yet to be seen, but the stage is set for this high-yield dividend payer to rebound. Shifts within the sell-side

Amazon Is Having Its Best Run In Years, But Should You Chase It?: https://www.marketbeat.com/logos/articles/med_20230705084627_amazon-is-having-its-best-run-in-years-but-should.jpg
Amazon Is Having Its Best Run In Years, But Should You Chase It?

With fellow tech heavyweights like Apple Inc (NASDAQ: AAPL), Meta Inc (NASDAQ: META), and Alphabet Inc (NASDAQ: GOOGL) all seeing strong rallies this year, it should be no surprise that Amazon Inc

Is The XLE Primed For A Potential Breakout?: https://www.marketbeat.com/logos/articles/med_20230705074040_is-the-xle-primed-for-a-potential-breakout.jpg
Is The XLE Primed For A Potential Breakout?

The Energy Select Sector SPDR Fund (NYSE: XLE) is setting up on a higher time frame for a potential breakout. YTD, the sector ETF is down almost 7%. However, as the uptrend remains intact and the

Next-Gen AI Datacenters Driving Applied Digital Stock up 400%: https://www.marketbeat.com/logos/articles/med_20230702163522_chart-apld.jpg
Next-Gen AI Datacenters Driving Applied Digital Stock up 400%

Next-generation data center solutions provider Applied Digital Co. (NASDAQ: APLD) stock exploded higher by over 400% in 2023. The company designs, constructs and operates high-performance

3 (AI) Plays That Could Rocket Higher In Q3: https://www.marketbeat.com/logos/articles/med_20230703134906_chart-amd-732023.png
3 (AI) Plays That Could Rocket Higher In Q3

AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is

What Does an Earnings Surprise Mean for American Outdoor Brands?: https://www.marketbeat.com/logos/articles/med_20230705071958_what-does-an-earnings-surprise-mean-for-american-o.jpg
What Does an Earnings Surprise Mean for American Outdoor Brands?

American Outdoor Brands, Inc. (NASDAQ: AOUT) delivered its fourth quarter and full-year earnings for its 2023 fiscal year on June 28, 2023. The company posted a surprise profit of six cents per

EV Makers Deliver Big...What it Means for Their Stocks: https://www.marketbeat.com/logos/articles/med_20230705072345_ev-makers-deliver-big.jpg
EV Makers Deliver Big...What it Means for Their Stocks

Global vehicle electrification is going full speed ahead.

A fleet of electric vehicle (EV) manufacturers provided monthly and quarterly updates over the weekend that can be summed up in one word

Goldman Sachs Reportedly Mulling Apple Card Move To Amex: https://www.marketbeat.com/logos/articles/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg
Goldman Sachs Reportedly Mulling Apple Card Move To Amex

The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected

2 Sizzling Mid-Caps That Could Stay Hot This Summer: https://www.marketbeat.com/logos/articles/med_20230705071628_2-sizzling-mid-caps-that-could-stay-hot-this-summe.jpg
2 Sizzling Mid-Caps That Could Stay Hot This Summer

Innovation looked quite different 40 years ago. The Internet was born. The Space Shuttle Challenger made its maiden voyage. The 3D printer was invented. Still, the tech-heavy Nasdaq Index surged

Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

-          Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods